Variant report

Variant	nsv462608
Chromosome Location	chr6:403799-442410
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:36)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:3)

No data

(count:36 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:412558..415332-chr6:420167..422817,2	K562	blood:
2	chr6:408215..411894-chr6:412351..416042,4	K562	blood:
3	chr6:402138..404117-chr6:404405..405938,2	K562	blood:
4	chr6:188540..189516-chr6:407870..409552,18	MCF-7	breast:
5	chr6:437166..439679-chr6:441319..444168,2	MCF-7	breast:
6	chr6:423651..426964-chr6:426983..431390,3	K562	blood:
7	chr6:189816..192061-chr6:402339..404478,2	K562	blood:
8	chr6:439020..441406-chr6:445866..448274,2	K562	blood:
9	chr6:423338..426540-chr6:426983..429484,4	K562	blood:
10	chr6:402138..404117-chr6:404405..405938,2	K562	blood:
11	chr6:417285..418861-chr6:423980..426711,2	MCF-7	breast:
12	chr6:188512..189290-chr6:408309..409342,5	K562	blood:
13	chr6:394972..397659-chr6:402039..404280,2	MCF-7	breast:
14	chr6:188538..189926-chr6:408487..409481,6	MCF-7	breast:
15	chr6:417285..418861-chr6:423980..426711,2	MCF-7	breast:
16	chr6:226916..227829-chr6:408545..409059,2	K562	blood:
17	chr6:328412..329240-chr6:408584..409212,2	MCF-7	breast:
18	chr6:402926..405329-chr6:407204..410322,3	K562	blood:
19	chr6:351167..352344-chr6:408672..409414,4	MCF-7	breast:
20	chr6:423338..426540-chr6:426983..429484,4	K562	blood:
21	chr6:402926..405329-chr6:407204..410322,3	K562	blood:
22	chr6:285371..287917-chr6:411939..414727,2	MCF-7	breast:
23	chr6:290942..293204-chr6:406060..408033,2	MCF-7	breast:
24	chr6:414625..416916-chr6:423887..426653,2	K562	blood:
25	chr6:440337..442812-chr6:446858..449559,2	MCF-7	breast:
26	chr6:391251..393259-chr6:408472..411329,2	K562	blood:
27	chr6:437166..439679-chr6:441319..444168,2	MCF-7	breast:
28	chr6:439906..443284-chr6:445258..447366,3	K562	blood:
29	chr6:217204..217743-chr6:408573..409085,2	K562	blood:
30	chr6:412558..415332-chr6:420167..422817,2	K562	blood:
31	chr6:408762..409286-chr6:489445..489959,2	MCF-7	breast:
32	chr6:408215..411894-chr6:412351..416042,4	K562	blood:
33	chr6:355994..357580-chr6:409667..411227,2	K562	blood:
34	chr6:423651..426964-chr6:426983..431390,3	K562	blood:
35	chr6:414625..416916-chr6:423887..426653,2	K562	blood:
36	chr6:291167..293410-chr6:407998..409657,2	MCF-7	breast:

No data

(count:3 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	IRF4	hsa-miR-125b-5p	chr6:408176-408197
2	IRF4	hsa-miR-125b-5p	chr6:408190-408197
3	IRF4	hsa-miR-125b-5p	chr6:410038-410062

Variant related genes	Relation type
ENSG00000137265	chromatin interactions
ENSG00000112679	chromatin interactions

Extended variants
information (count: 1886 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:1886 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3778607	chr6:403799-403800	Weak transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs564826978	chr6:403815-403816	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs375289958	chr6:403816-403817	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs577145521	chr6:403821-403822	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs550892741	chr6:403858-403859	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs567510865	chr6:403890-403891	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs536433583	chr6:403904-403905	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs189483096	chr6:403910-403911	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs11290709	chr6:403959-403960	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs79767420	chr6:403970-403971	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs566977582	chr6:404050-404051	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs570386923	chr6:404093-404094	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs538724495	chr6:404098-404099	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs558538437	chr6:404120-404121	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs575229265	chr6:404123-404124	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs538185885	chr6:404188-404189	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs180712077	chr6:404198-404199	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs371713355	chr6:404238-404239	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs113567718	chr6:404245-404246	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs73717076	chr6:404279-404280	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs184991834	chr6:404287-404288	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs539396256	chr6:404334-404335	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs572902341	chr6:404347-404348	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs367942611	chr6:404356-404357	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs545074075	chr6:404370-404371	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs368001042	chr6:404372-404373	Weak transcription Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs555711360	chr6:404401-404402	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs138303497	chr6:404410-404411	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs377532460	chr6:404420-404421	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs118040333	chr6:404449-404450	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs550931495	chr6:404495-404496	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs561146228	chr6:404500-404501	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs529919146	chr6:404506-404507	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs546789603	chr6:404515-404516	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs566508055	chr6:404531-404532	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs138625335	chr6:404540-404541	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs575749179	chr6:404541-404542	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs73717077	chr6:404571-404572	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs552243058	chr6:404584-404585	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs568945229	chr6:404592-404593	Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs2001508	chr6:404632-404633	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs368433545	chr6:404637-404638	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs117897038	chr6:404640-404641	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs539448722	chr6:404652-404653	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs572598390	chr6:404688-404689	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs534183725	chr6:404702-404703	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs115371721	chr6:404705-404706	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs577365076	chr6:404707-404708	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs545167234	chr6:404738-404739	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs141870842	chr6:404739-404740	Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS Enhancers Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Prader-willi syndrome	20588305	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21364760	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:416 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:392000-406400	Transcr. at gene 5' and 3'	Primary T helper cells PMA-I stimulated	--
2	chr6:394400-405800	Genic enhancers	Primary B cells from peripheral blood	blood
3	chr6:395000-411200	Weak transcription	Right Atrium	heart
4	chr6:397000-406000	Transcr. at gene 5' and 3'	GM12878-XiMat	blood
5	chr6:398400-408400	Weak transcription	Adipose Nuclei	Adipose
6	chr6:398600-405000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr6:398600-407400	Weak transcription	Rectal Smooth Muscle	rectum
8	chr6:398800-408200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
9	chr6:400600-406600	Weak transcription	Gastric	stomach
10	chr6:400800-406000	Strong transcription	Monocytes-CD14+_RO01746	blood
11	chr6:401000-404800	Transcr. at gene 5' and 3'	Foreskin Melanocyte Primary Cells skin03	Skin
12	chr6:401200-405000	Transcr. at gene 5' and 3'	Primary T helper 17 cells PMA-I stimulated	--
13	chr6:401200-405000	Transcr. at gene 5' and 3'	Foreskin Melanocyte Primary Cells skin01	Skin
14	chr6:401800-411800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr6:402000-411000	Weak transcription	Thymus	Thymus
16	chr6:402400-403800	Enhancers	Primary T cells from cord blood	blood
17	chr6:402400-405400	Enhancers	Fetal Thymus	thymus
18	chr6:402400-407800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
19	chr6:402600-404600	Genic enhancers	Primary B cells from cord blood	blood
20	chr6:403000-403800	Genic enhancers	Primary T cells fromperipheralblood	blood
21	chr6:403000-403800	Genic enhancers	Primary Natural Killer cells fromperipheralblood	blood
22	chr6:403000-404200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
23	chr6:403000-404400	Enhancers	Primary T helper naive cells from peripheral blood	blood
24	chr6:403000-405400	Enhancers	Primary T killer memory cells from peripheral blood	blood
25	chr6:403200-403800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
26	chr6:403200-403800	Enhancers	Placenta Amnion	Placenta Amnion
27	chr6:403200-404800	Enhancers	Rectal Mucosa Donor 29	rectum
28	chr6:403200-405200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
29	chr6:403200-405400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
30	chr6:403400-403800	Genic enhancers	Spleen	Spleen
31	chr6:403400-404000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
32	chr6:403400-404400	Weak transcription	Primary monocytes fromperipheralblood	blood
33	chr6:403600-404200	Enhancers	Rectal Mucosa Donor 31	rectum
34	chr6:403600-404600	Enhancers	Duodenum Mucosa	Duodenum
35	chr6:403600-404800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
36	chr6:403600-405200	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
37	chr6:403600-406200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
38	chr6:403800-404000	Bivalent Enhancer	Stomach Mucosa	stomach
39	chr6:403800-404600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
40	chr6:403800-404800	Enhancers	Primary T cells fromperipheralblood	blood
41	chr6:403800-405400	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
42	chr6:403800-405600	Flanking Active TSS	Primary T cells from cord blood	blood
43	chr6:403800-410400	Weak transcription	Spleen	Spleen
44	chr6:403800-411600	Weak transcription	Placenta Amnion	Placenta Amnion
45	chr6:404000-404600	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
46	chr6:404000-404600	Bivalent Enhancer	K562	blood
47	chr6:404200-404400	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
48	chr6:404200-404600	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
49	chr6:404400-404600	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
50	chr6:404400-404800	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links